What factors drove the growth of the animal health unit?

Growth was driven by MFA products, vaccines, and global expansion.

Did the report mention the performance of other business units?

No specific details were provided, but it noted pressures in other units.

Phibro Animal Health Unit Drives 74% of Fiscal 2025 Revenue

Phibro Animal Health's animal health unit accounted for 74% of fiscal 2025 revenue, fueled by MFA products, vaccines, and global expansion, helping offset pressures in other business segments.

June 12, 2026

2 min read

Source: Zacks

Key Numbers

fiscal 2025 revenue share

74%

According to a Zacks report, Phibro Animal Health's (PAHC) animal health unit was the primary revenue driver in fiscal 2025, contributing 74% of total revenue. This growth was mainly fueled by MFA products, vaccines, and global expansion.

Details

The report noted that the animal health unit benefited from strong demand for MFA (Mineral Feed Additives) and veterinary vaccines, helping to offset pressures in other business units. Geographic expansion into new markets also boosted revenue.

Context

These results come as Merck (MRK) faces competition in the animal health sector, where Phibro is a key player. The report did not provide specific details on the performance of other units.

What It Means for Investors

The strong growth in the animal health unit underscores Phibro's focus on a sector with increasing demand, potentially boosting investor confidence in the company's ability to achieve sustainable growth despite challenges in other areas.

Frequently Asked Questions

The animal health unit contributed 74% of total fiscal 2025 revenue.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.